Drugmaker Lilly reports 5 pct rise in quarterly sales

Jan 28 (Reuters) - Drugmaker Eli Lilly and Co reported a 5 percent rise in quarterly sales, helped by higher sales of its diabetes drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.